Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
Yutaka Yamamoto(Kindai University), Hirotsugu Uemura(Kindai University)
Cited by 17
Related Papers
Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway
|Advances in Urology|2012|17